Product introduction
Eurepa-V 1/0.3 Tablet is a combination of two medicines used to treat type 2 diabetes mellitus. It helps control the high blood sugar levels in your body after each meal. It is used when other similar medicines along with a restricted diet, are unable to control abnormally high blood sugar levels.
Eurepa-V 1/0.3 Tablet should be taken just after meals. The dose will be decided by your doctor. Do not stop taking it without asking your doctor. If you do, your blood sugar levels may increase and put you at risk of serious complications like kidney damage and blindness. If you miss a dose, do not take the missed dose between two meals. Wait until your next meal and take it just after meals as usual. Do not take a double dose to make up for the missed dose. This medicine is only part of a treatment program that should include a healthy diet, regular exercise, and weight reduction as advised by your doctor.
The most common side effects of this medicine include flatulence, diarrhea, stomach pain, hypoglycemia (low blood sugar level), and skin rash. However, these are temporary and usually resolve on their own. Please consult your doctor if these do not resolve or persist for a longer duration. Monitor your blood sugar levels regularly while taking this medicine.
Before taking this medicine, inform your doctor if you have any kidney or liver problems or urinary tract infection or if you are on water pills (diuretics). Pregnant or breastfeeding women should also consult their doctor before taking it. Avoid excessive alcohol intake while taking it as this may increase the risk of developing some side effects.
Uses of Eurepa-V Tablet
- Treatment of Type 2 diabetes mellitus
Benefits of Eurepa-V Tablet
In Treatment of Type 2 diabetes mellitus
Eurepa-V 1/0.3 Tablet is a medicine that helps to control high blood glucose (sugar) levels. It helps get rid of extra glucose from your body through urine. It helps to slow down the breaking down of food in our intestine to simple glucose (sugar), thereby decreasing the rise in blood glucose levels after meals. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level, you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems and loss of limbs.
Eurepa-V 1/0.3 Tablet will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.
Eurepa-V 1/0.3 Tablet will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.
Side effects of Eurepa-V Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Eurepa-V
- Headache
- Hypoglycemia (low blood glucose level)
- Abdominal pain
- Diarrhea
- Flatulence
How to use Eurepa-V Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Eurepa-V 1/0.3 Tablet is to be taken on an empty stomach.
How Eurepa-V Tablet works
Repaglinide and voglibose help control blood sugar levels in people with type 2 diabetes. Repaglinide increases the release of insulin after meals, helping the body manage rises in blood sugar. Voglibose slows down the digestion and absorption of carbohydrates from food, which helps prevent sudden spikes in blood sugar after eating. Together, they support better post-meal blood sugar control.
Safety advice
Alcohol
CAUTION
Alcohol should be used with caution while taking Eurepa-V 1/0.3 Tablet.
Pregnancy
CONSULT YOUR DOCTOR
Eurepa-V 1/0.3 Tablet is not recommended during pregnancy as there is positive evidence of fetal risk based on animal studies. However, it may still be prescribed by a doctor in situations where the benefits outweigh the risks.
Breast feeding
UNSAFE
Eurepa-V 1/0.3 Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Driving
CAUTION
Eurepa-V 1/0.3 Tablet may affect your driving ability if your blood sugar becomes too low or too high. Monitor your blood glucose and avoid driving if affected.
Kidney
CAUTION
Eurepa-V 1/0.3 Tablet should be used with caution in patients with severe kidney disease. Dose adjustment may be needed.
Liver
CAUTION
Eurepa-V 1/0.3 Tablet should be used with caution in patients with severe liver disease. Dose adjustment may be needed.
What if you forget to take Eurepa-V Tablet?
If you miss a dose of Eurepa-V 1/0.3 Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
| Weight | 11 g |
|---|
General Inquiries
There are no inquiries yet.
Related products
Customer reviews
Reviews
There are no reviews yet.
Only logged in customers who have purchased this product may leave a review.